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Abstract
Background: Electroporation is a method of disrupting the integrity of cell membrane by electric pulses (EPs). Electrical
modeling is widely employed to explain and study electroporation, but even most advanced models show limited
predictive power. No studies have accounted for the biological consequences of electroporation as a factor that alters the
cell’s susceptibility to forthcoming EPs.
Methodology/Principal Findings: We focused first on the role of EP rate for membrane permeabilization and lethal effects
in mammalian cells. The rate was varied from 0.001 to 2,000 Hz while keeping other parameters constant (2 to 3,750 pulses
of 60-ns to 9-ms duration, 1.8 to 13.3 kV/cm). The efficiency of all EP treatments was minimal at high rates and started to
increase gradually when the rate decreased below a certain value. Although this value ranged widely (0.1–500 Hz), it always
corresponded to the overall treatment duration near 10 s. We further found that longer exposures were more efficient
irrespective of the EP rate, and that splitting a high-rate EP train in two fractions with 1–5 min delay enhanced the effects
severalfold.
Conclusions/Significance: For varied experimental conditions, EPs triggered a delayed and gradual sensitization to EPs.
When a portion of a multi-pulse exposure was delivered to already sensitized cells, the overall effect markedly increased.
Because of the sensitization, the lethality in EP-treated cells could be increased from 0 to 90% simply by increasing the
exposure duration, or the exposure dose could be reduced twofold without reducing the effect. Many applications of
electroporation can benefit from accounting for sensitization, by organizing the exposure either to maximize sensitization
(e.g., for sterilization) or, for other applications, to completely or partially avoid it. In particular, harmful side effects of
electroporation-based therapies (electrochemotherapy, gene therapies, tumor ablation) include convulsions, pain, heart
fibrillation, and thermal damage. Sensitization can potentially be employed to reduce these side effects while preserving or
increasing therapeutic efficiency.
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Introduction
Electroporation of cell membranes by EPs, also known as
electropermeabilization, has been extensively studied for several
decades. Experimental studies ranged from lipid bilayers and
liposomes to both pro- and eukaryotic cells in culture and various
tissues in vivo. Multiple theoretical studies explored the phenom-
enon of electropermeabilization by molecular dynamics, sophisti-
cated electrical circuit modeling, and numerical simulations. Still,
the mechanisms of electroporation itself and of electroporation-
induced biological phenomena have not been fully understood,
which stimulated a new surge of interest in the topic and numerous
recent publications, e.g. [1–16].
Notwithstanding gaps in knowledge, electroporation has both
well-established and developing applications for gene electro-
transfer and gene therapy [14,16–19] cell fusion [20–22], elec-
trochemotherapy [23,24], tumor ablation [3,5,13,25], vascular
smooth muscle cells ablation [4], sterilization [26,27], and food pro-
cessing [28,29]. Numerous studies have focused on optimization of
exposure conditions to produce maximum desired effect while
minimizing side effects. However, with multiple parameters to
consider (E-field, pulse duration, number of pulses, their shape and
repetition frequency) these studies have been laborious and showed
limited success. The optimization process remains mostly empirical,
whereas quantitative and mechanistic principles that determine the
outcome of EP exposures are debated [7–10,15,30–32].
Out of different EP exposure parameters, the impact of the
pulse repetition frequency (PRF) is the least understood, resulting
in controversial findings and treatment recommendations. Aside
from the trivial heating effect that increases with increased PRF
(less time for heat dissipation), experimental and theoretical studies
using different endpoints reported significantly greater bioeffects at
higher PRF [2,13,16,30,33–35], significantly greater effects at
lower PRF [1,4,5,10,25,29,36–38], biphasic or more complex
dependences [30,38,39], or relatively little role of PRF within
studied limits [2,8,38,40].
Specifically, Vernier et al. [34] reported significant uptake of
membrane impermeable dyes (propidium and YO-PRO-1) when
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17100Jurkat cells were exposed to 30 pulses (4-ns duration, 80 kV/cm)
at 1 and 10 kHz rates. No dye influx was detected at the lower
rates of 10 and 100 Hz. Jiang and Cooper [35] showed the
reduction of the E-field threshold for nociceptor excitation from 30
to 24 and to 16 V/cm as the PRF was increased from 100 Hz to 1
and 4 kHz, respectively (for a train of one hundred 12-ns pulses).
Similarly, applying 100-ms pulses at intervals under 1 ms lowered
the electroporation threshold of artificial bilayer lipid mem-
branes [33].
Increasing PRF from 0.1 to 1, 10, and 77 Hz (six 1-ms pulses at
800 V/cm) decreased the 24-hr survival of exposed CHO cells
from 60% (0.1 Hz) to about 20% (77 Hz) [16]. Likewise, a train of
2,000 pulses (100-ns duration, 30 kV/cm) was more efficient in
eliminating murine melanomas at PRF of 5 and 7 Hz when
compared to 1 or 3 Hz [13]; however, the statistical significance of
this finding was not evaluated. Overall, higher efficiency of higher
PRF is usually attributed to the temporal summation of brief
subthreshold effects (or lesions) which can recover without con-
sequences if the interval between pulses is sufficiently long.
In contrast to the above studies, Rubinsky and co-authors
observed more efficient cell killing at lower PRF, both in vitro and
in vivo [4,5,25,37]. The authors typically adjusted several exposure
parameters at once (in order to keep the cumulative EP duration
or the total dose unchanged), so isolating ‘‘pure’’ effects of PRF
may be not straightforward. Still, one can find that, for example,
eight 1-ms pulses at 2.5 kV/cm were more efficient at 0.03 Hz
than at 0.3 Hz; or eighty 100-ms pulses at 2.5 kV/cm were more
efficient at 0.3 Hz than at 3 Hz (see Fig. 2 in [25]). When the
delivered energy was kept constant, longer exposures at the lower
E-field and using greater number of pulses typically were more
efficient, despite lower temperature rise. Gradual enhancement of
the cytotoxic effect as the PRF decreased from 5 kHz to 1 kHz,
60 Hz, and 1 Hz was also reported in SKOV3 cells exposed to
exponentially-decaying EPs [36]. The reason for higher efficiency
of lower PRF has not been identified, but it may be related to the
reduction of EP efficiency when the cell membrane is made
‘‘leaky’’ by the previous EPs [9,39]. With longer inter-pulse
intervals, the membrane partially reseals and the efficiency of the
coming pulses increases. Simulation studies showed an overall slow
decrease of the fractional area of pores with PRF increase,
however, with sharp regular troughs at certain frequencies [39].
Pucihar and co-authors [38] found that the uptake of Lucifer
Yellow dye by DC3F cells exposed to 26 pulses of 30-ms duration
was the same for 1 Hz and 8.3 kHz, however, it required about
1.5 times higher E-field for the higher PRF. The dependence was
similar for 100-ms pulses, except for a slightly higher dye uptake at
10 Hz compared to both lower (1 Hz) and higher PRF (1 and
2.5 kHz).
For a train of 200 pulses of 50-ms at 0.9 kV/cm, the cytotoxic
effect in CHO cells showed a bell-shaped dependence on PRF: it
was weaker at the central frequency of 10 Hz, and gradually
enhanced as the rate either decreased to 0.5 Hz or increased to
100 Hz [30]. At the same time, propidium uptake by the cells was
flat for the range from 0.5 to 20 Hz, and increased at 50 and
100 Hz. The authors hypothesized that the increased cytotoxicity
at the lowest PRF may be related to slow rotation of cells in
suspension, so that different portions of their membrane get
exposed to the field and more membrane is porated. This idea was
later extended into a complex model that related random
statistical rotations of suspension cells to EP efficiency [10].
In the field of electrochemotherapy, a significant effort has been
made in recent years to compare 1 Hz and 5 kHz delivery rates of
100-ms pulses. The advantage of the 5 kHz PRF was alleviation of
pain and discomfort from EP application, whereas its anti-tumor
efficiency was either similar, or somewhat higher, or somewhat
lower, depending on the concurrent conditions and the method of
assessment (for discussion, see [1,40–42]).
Importantly, none of the above-mentioned studies was specifi-
cally focused on the role of PRF; instead, it was just one of variables
evaluated alongside other parameters of interest. The lack of
comprehensive, wide scale studies may explain, at least partially, the
controversyconcerningPRF impact andmechanisms involved.The
present study was originally conceived just to fill this void;
unexpectedly, it revealed an all-new phenomenon of EP-induced
sensitization to subsequent EP deliveries. This gradually developing
sensitization is a biological response of living cells and, not
surprisingly, it was not predicted or considered by any models
which viewed EP effects solely as an electrochemical process.
Taking sensitization into account greatly complements understand-
ingof the reported electroporationfindings and helps to designmost
effective EP treatment regimens for various applications.
Results
Effect of PRF on long-term cell survival
Fig. 1 (left column) summarizes the results of multiple ex-
periments that tested the cytotoxic efficiency of EP trains delivered
at different PRF. Each plot corresponds to an independent set of
experiments where the E-field, pulse duration, and the number of
pulses were kept constant, while the PRF was the only parameter
varied. Overall, these experiments explored rather diverse exposure
conditions: 300 ns to 9 ms pulse duration, 1.8 to 9 kV/cm E-field, 2
to 500 pulses per train, at 0.001 to 1,000 Hz PRF. In addition, the
experimentswereperformedintwocelllines(JurkatandU937),and
cell survival was measured by different methods.
Regardless of the specific conditions tested, maximum cell
killing in all experiments was achieved at the lowest tested PRF. As
the PRF increased, the effect gradually weakened and reached a
plateau at higher frequencies. Surprisingly, the level at which the
plateau was reached differed more than 1000-fold from one set of
experiments to another. The bottom graph in the left column of
Fig. 1 shows that the increase of the EP efficiency from the
minimum plateau level occurred at PRFs as different as 0.1–
500 Hz. Such diversity was difficult to explain, and it also
suggested that perhaps it was not the PRF that actually determined
the increased effect at the lower pulse rates.
To check this idea, the same data were re-plotted against the
total duration of the treatment, which was simply a ratio of the
pulse number to the PRF (Fig. 1, right column). The data from the
different sets of experiments now showed much better agreement:
in all cases, the transition from the plateau to higher cytotoxic
efficiency corresponded to the treatment duration of about 10 sec
(Fig. 1, bottom graph in the right column).
Interpretation of this finding is easier when considering the
exposures that consisted of only two pulses (three graphs
immediately above the combined plots). In this case, the treatment
duration was simply the interval between the pulses, and the
cytotoxic efficiency increased once a certain interval was exceeded.
These data prompt that the first pulse somehow conditioned the
cells, making them more sensitive to the second pulse if it is
delivered after a proper delay. The validity of this explanation also
for multi-pulse treatments is confirmed below by exposure
fractionation.
Fractionated exposure: a new approach to increase the
EP efficiency
We showed in Fig. 1 that the EP cytotoxic effect is enhanced
when the total duration of the treatment exceeds a certain
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change in PRF, we needed to increase the treatment duration
while keeping both the PRF and the number of pulses constant.
The only feasible way to do it was splitting of a high rate EP train
into separate fractions separated by a long quiescent period. The
effect of such exposure fractionation is illustrated in Fig. 2, A. The
same train of 150 pulses (300 ns, 9 kV/cm) was far more efficient
at 1 Hz than at 1,000 Hz; the respective train durations and cell
Figure 1. The effect of the pulse repetition rate (left column) and of the total duration of the treatment (right column) on cell
survival. Each plot (except those at the bottom) represents a separate series of experiments where cells were exposed to a fixed number of pulses of
a given amplitude and duration (see legends within the figure; e.g., for the top plot the legend means ‘‘500 pulses of 0.3 ms duration at 4.5 kV/cm).
The only variable in each series was the pulse repetition rate and, consequentially, the total duration of the treatment. Other data in the legends are
the cell type and the timepoint after exposure when the cell survival was measured. At 4 hr, cell survival was measured using dye exclusion/
quenching method; at 24 hr, it was measured using MTT assay (see ‘‘Methods’’ for detail). Each datapoint is the mean +/2 s.e for 3–12 independent
experiments. For the bottom plots, the curves from all series of experiments were collapsed together; shown are only the connecting lines; the mean
value symbols and error bars have been omitted for clarity. See text for more detail.
doi:10.1371/journal.pone.0017100.g001
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37+/22.8% (p,0.01, Student’s t-test). However, when the 1,000-
Hz train was split into two fractions (75 pulses, 0.75 s each)
separated by a 150-s interval, the resulting cell survival dropped to
10.6+/21.1%, i.e., it became the same as after the 1-Hz, 150-s
exposure.
This finding unequivocally demonstrates that it was indeed the
treatment duration, rather than a particular PRF, that determined
the enhancement of the cytotoxic effect. When the duration of the
1,000-Hz EP treatment was increased by splitting one train in two
fractions to match the duration of the 1-Hz treatment, both the
1000-Hz and 1-Hz exposures had the same effect.
Fig. 2, B shows that fractionation enhanced the effect for
different exposure conditions, but excluding those when the E-field
was reduced to a sub-threshold value (1.8 kV/cm). When a single
train had no appreciable effect on cell survival, splitting it in
fractions had no additional effect.
However, the lack of appreciable cytotoxic effect of a high-PRF
exposure does not necessarily always indicate the lack of
subthreshold lesions. Under certain conditions, such subthreshold
lesions can be amplified by slower or fractionated treatments to
cause a profound drop in survival (e.g., see Fig. 1, 5th curve from
the top).
We further demonstrated that the enhancement of EP effect by
exposure fractionation depends on the fraction size (Fig. 3). A train
of 600 pulses (300 ns, 4.5 or 9 kV/cm) was delivered either as a
single train (100% pulses in the first train), or as two trains of
varied pulse contents, with a 6-min interval between the trains. For
example, 1% dose fraction in the 1st train corresponded to 6
pulses in the first train followed by 594 in the 2nd train 6 min
later; 10% was 60 pulses in the 1st train and 540 in the 2nd one,
and so forth. Although the best fit curves showed maximum
efficiency as dose fraction ratio approached 50%, the effect was
essentially flat within a wide range of dose fractions, from 10–20 to
80–90%. However, with the smallest fraction (1%), the effect was
not different from a single-train exposure, irrespective of the fact
that the fractionated exposure lasted 6 min and the single train
was delivered in 0.6 s.
EP-induced propidium uptake and membrane rupture in
substrate-attached cells
Several earlier studies attributed the enhanced effect of low PRF
to slow, random rotation of cells in suspension, so that different
portions of cell membrane face the electrodes and get permeabilized
by EP [10,30]. While this explanation did not explain well our
observations, the only way to unequivocally rule out the impact of
rotation was to replicate the findings in substrate-attached cells. In
addition, it was deemed important to replicate the principal findings
about PRF and fractionation using a different EP generation and
delivery setup, different experiment protocol, and making mea-
surements in individual selected cells rather than in bulk suspension.
Figure 2. Enhancement of the EP cytotoxic effect by exposure
fractionation. U937 cells were exposed 0.3-ms EPs; the pulse number,
amplitude, and delivery mode, are indicated in the figure. Cell survival
was measured as a percentage of propidium-excluding cells at 4 hr post
exposure (mean +/2 s.e., n=3–7). Survival in sham-exposed samples
was over 95% (data not shown). A: Exposure to 150 pulses was
significantly more effective at 1 Hz than at 1,000 Hz. However, splitting
the 1,000-Hz train in two fractions of 75 pulses each, with a 150-s
interval, made it as efficient as the 1-Hz treatment. B: Splitting of a
single high-rate train in two same size fractions with 150-s interval
enhanced the effect EP of 4.5 and 3 kV/cm EPs, but not at the lower EP
amplitude of 1.8 kV/cm.
doi:10.1371/journal.pone.0017100.g002
Figure 3. The role of fraction size in the enhancement of the EP
effect by fractionation. Survival of U937 cells was determined by
propidium exclusion at 4 hr following exposure to 0.3 ms EPs at either
4.5 kV/cm (top graph) or 9 kV/cm. The total number of 600 pulses was
split into two fractions which were delivered with a 6-min interval. The
number of pulses in the first train varied form 1% to 100% of the total.
The latter value corresponded to delivering all pulses in a single train,
and the respective survival levels are shown by shaded areas. Mean+/2
s.e., n=4–6. Solid lines are best fit approximations using second degree
polynomial function. Dashed lines delimit the borders of 95%
confidence intervals for the best fit.
doi:10.1371/journal.pone.0017100.g003
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individual cells to monitor and quantify propidium (Pr) uptake in
CHO cells attached to a coverslip. At high enough treatment
intensity (we used a train of 100 pulses, 60 ns duration, at
13.3 kV/cm), the exposure could cause two distinct types of Pr
uptake: a transient uptake (during and immediately after EP) and a
delayed, accelerated uptake (Fig. 4).
The transient uptake was characterized by an abrupt increase of
the fluorescent signal during and immediately after the exposure,
reflecting Pr entry and binding to nucleic acids. Pr fluorescence
due to the transient uptake reached a plateau within about 1 min,
and remained at this level for the rest of the observation period
(30 min).
In some EP-treated cells, the transient uptake was eventually
followed by a delayed, more intense, and gradually accelerating Pr
uptake (until reaching the detector saturation). Whereas the
transient uptake is an immediate and direct manifestation of
electroporation, the delayed/accelerated uptake is a sign of
irreversible membrane rupture when a cell fails to promptly
repair the EP-induced membrane lesions. The development of the
delayed/accelerated Pr uptake was probably a result of multiple
parameters (such as cell shape, size, exact position with respect to
the electrodes, stage in cell cycle, shielding by other cells), but
showed no clear association with any of them. These two modes of
Pr uptake were also reported by other investigators for nano- and
microsecond duration EP treatments [43]; the most likely reason
for delayed membrane rupture is limited electropore permeability
and gradual cell swelling by the colloid osmotic mechanism
[44,45].
Fig. 5 compares the incidence of membrane rupture (as
reflected by the delayed Pr uptake) for different rates and protocols
of EP exposure, when the E-field, pulse duration, and pulse
number were kept the same. For better viewing, cells that showed
only transient uptake are separated from those that developed
both transient and delayed uptake.
Fig 5, A shows that the incidence of membrane rupture resulting
from exposure to a single EP train (100 pulses at 13.3 kV/cm,
60-ns pulse duration) increased with decreasing the PRF, namely
from 29% at 20 Hz to 47% at 2 Hz, and 56% at 0.01 Hz. Same
as in the cell survival experiments described above, the lowest PRF
was the most efficient.
Fig 5, B shows a separate set of experiments, where 20 Hz and
0.2 Hz treatments served both as an independent replication of
the experiments in Fig. 5, A, and as reference points for efficiency
of the fractionated 20-Hz exposures. For unknown reasons, the
effects of both 20- and 0.2-Hz exposures in set B were somewhat
greater than previously in A (p.0.05), but the higher efficiency of
the 0.2 Hz compared to 20 Hz (single train) remained very
consistent (p,0.002 for A and B data pooled together, two-tailed
Fisher Exact Probability test). Both fractionated 20-Hz exposures
(20+80 pulses or 80+20 pulses, with 250-s interval) were more
effective than a single 20-Hz train, approaching the efficiency of
the 0.2-Hz exposure.
Overall, the PRF and dose fractionation had the same effect in
the attached cells as in the suspended cells (as described in the
previous sections), despite looking at a different endpoints, using
shorter (60-ns) EP, and employing an entirely different setup for
EP generation and delivery.
Figure 4. Two distinct modes of propidium uptake in EP-exposed cells. A group of three CHO cells attached to a coverslip was exposed to
an EP train at 50 s into the experiment. Exposure parameters are indicated in the figure. Insets show differential-interference contrast and fluorescent
images of cells at selected timepoints. Scale bars: 10 mm. The images were taken every 10 s throughout the experiment. The graph shows the time
dynamics of Pr uptake by cells 1, 2 and 3. Note the immediate increase in Pr fluorescence in all three cells, caused by electropore opening and
transient Pr uptake. Following the transient uptake, the intensity of fluorescence displayed little changes until membrane rupture and massive Pr
entry in cells 1 and 2, but not in cell 3.
doi:10.1371/journal.pone.0017100.g004
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In experiments described above, we changed pulse delivery
protocols while keeping the exposure dose constant (including
same E-field, same number and duration of pulses). Now, we chose
two exposure protocols (a single high-rate train versus same train
split in two fractions) and compared their efficiencies within a wide
range of doses.
As shown in Fig. 6, the same cytotoxic effect was achieved at
significantly lower doses when using the fractionated treatment.
Doses that killed 50% and 90% of cells (LD50 and LD90) were 2–
2.5 times lower for the fractionated exposures. This result can
potentially be further improved by careful optimization of different
exposure parameters; at this time, the 2-fold dose reduction can
serve as a ballpark estimate of the benefits that can be achieved by
exposure fractionation in various EP applications.
Discussion
The principal finding of our study is that the efficiency of varied
EP treatments increased when the treatment duration was made
sufficiently long, either by applying pulses at a low rate, or by
splitting a single pulse train into separate fractions. This increase in
efficiency is explained by a gradual and delayed increase in the EP
susceptibilityduringthe exposure procedure. Inotherwords, the EP
(or EPs) that are delivered first cause sensitization to subsequently
delivered EPs, thereby increasing their effect and making the entire
EP treatment more efficient. It is well established that the principal
and primary effect of intense electric pulses in living cells is
electroporation of the cell plasma membrane, which allows us to
interpret the observed increase in EP efficiency as the electropo-
ration-induced electrosensitization.
In the Introduction, we have discussed the studies that
attempted to explain various pulse rate effects relying solely on
the physical effects of the applied electric field. However, none of
these explanations can explain the delayed sensitization (which
requires at least 10–100 sec of the total treatment duration) or
predict the effect of the fractionated treatments. The data point to
a biological rather than merely physical mechanism of sensitiza-
tion, and below we discuss several hypothetic scenarios of what
cellular events could lead to sensitization.
Figure 5. The effect of PRF (A, B) and exposure fractionation (B) on the incidence of delayed membrane rupture in EP-exposed CHO
cells. A and B are two separate and independent series of experiments; within each series, different exposure regimens were alternated in random
order. Membrane integrity was probed by Pr uptake; each curve corresponds to Pr uptake in an individual exposed cell, as measured by cell imaging
every 10 s throughout the experiment. EP exposure caused transient Pr uptake due to electroporation in all cells and delayed/accelerated Pr uptake
due to secondary membrane rupture in some cells (see Fig. 4 and text for more detail). For clarity, for each type of treatment, cells that showed only
transient Pr uptake (blue curves, bottom graphs) are separated from cells that showed both transient and delayed Pr uptake (red curves, top graphs).
The number of cells that fell into each of the two categories is shown to the right of the graphs. In all groups, cells were exposed to 100, 60-ns pulses
at 13.3 kV/cm, whereas the PRF and pulse delivery protocols varied (see legends in the figure). The legends also give the percent of ruptured cells in
each group. Note the increase of EP exposure efficiency at lower PRF (A and B) and also when the 20-Hz train was split in two fractions (B). Single-
train 20- and 0.2-Hz exposures in A and B are identical treatments, although in B both showed somewhat higher efficiency.
doi:10.1371/journal.pone.0017100.g005
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exposure, the ions from the extracellular medium diffuse into the
cell, down the concentration and electrochemical gradients,
whereas the intracellular ions leave the cell. The cell attempts to
restore the ion gradients and membrane potential by activating ion
pumps and repairing the membrane [46,47]. High energy
expenditure for these processes may be aggravated by ATP
leakage out of cell through the electropores. One can speculate
that a prolonged high demand for ATP combined with ATP loss
during longer exposures could be a factor responsible for
sensitization.
Among ions that can enter through the electropores, Ca
2+ will
have multiple effects on cell physiology. It is not clear how exactly
the increased Ca
2+ concentration would change the cell suscep-
tibility to EP, but it should come as no surprise that prolonged
time intervals when the internal Ca
2+ is elevated (e.g., due to a
longer EP treatment) may be unfavorable for cells and make them
more vulnerable.
Plasma membrane permeabilization also triggers cell volume
changes due to the so-called colloid osmotic mechanism [45,48].
In a ‘‘typical’’ bath buffer, as well as in the cell growth medium,
permeabilization leads to water uptake and cell swelling. The
increase of cell diameter translates into a higher induced
membrane potential when next EPs are applied [22], which
makes electroporation more efficient. Furthermore, the additional
membrane for cell swelling is recruited from cytoplasmic
invaginations of the plasma membrane, and this ‘‘spreading out’’
of the membrane could also contribute to increasing EP effects.
Notably, considering these mechanisms helps to reconcile the
seemingly contradictory studies that reported diverse effects of
PRF. For example, Faurie and co-authors [16] reported greater
cytotoxic effect of 1-ms pulses as the PRF was increased from 0.1
to 77 Hz, which is the opposite of what was shown in our work
and other studies [4,5,25,37]. It appears that the critical distinction
of this study was composition of the pulsing medium, which
contained 250 mM sucrose, 1 mM MgCl2, and 10 mM of
K2HPO4/KH2PO4 buffer [16]. In this medium, membrane
electroporation obviously will not lead to any Ca
2+ or Na
+ uptake,
and cell swelling will be weaker or even replaced by shrinking.
Thus, the lack of electroporation-induced electrosensitization in
this pulsing medium is consistent with the involvement of one or
several mechanisms mentioned above.
Figure 6. Effective reduction of the lethal dose (LD) by exposure fractionation. U937 cells were exposed to 100 (left) or 200 (right) of 0.3-ms
duration EPs. The exposure was delivered either as a single train or as two equal fractions (50+50 and 100+100) with a 5-min interval. EPs were
applied at different E-fields amplitudes (values are given above the abscissa), resulting in different absorbed doses. The graphs show cell survival
(mean+/2 s.e., n=3–6) versus the dose for different EP treatments. Dashed lines are the best fit data approximations using exponential function;
shaded areas denote 95% confidence intervals. Cell survival was measured by propidium exclusion at 4 hr post exposure. Legends show LD values for
elimination of 50% and 90% of cells (LD50 and LD90) by the tested exposure protocols.
doi:10.1371/journal.pone.0017100.g006
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involve direct or indirect oxidative damage to membrane by EP
exposure [49–51], which would enhance its susceptibility to
permeabilization by EPs [52].
Although the exact sequence of events resulting in electro-
sensitization has yet to be identified, taking this phenomenon into
account helps to explain contradictions in published data, and will
likely be beneficial for many existing and coming applications of
electroporation. Controlled cell destruction with minimum side
effects and energy expenditure is the principal endpoint in tissue
and tumor ablation, sterilization, and food processing, whereas in
other applications such as gene electrotransfer, the cell death is a
major outcome to avoid. Engaging (or preventing) electrosensitiza-
tion by changing pulse rate and by exposure fractionation can be a
simple and efficient approach to achieve the desired goals of
various electroporation treatments.
Materials and Methods
Cell lines and propagation
Experiments were performed in two suspension cell lines (Jurkat
clone E6-1, human T-lymphocytes, and U-937, human mono-
cytes) and one anchor-dependent cell line (CHO-K1, Chinese
hamster ovary). The cells were obtained from ATCC (Manassas,
VA) and propagated at 37uC with 5% CO2 in air according to
supplier’s recommendations. Jurkat and U-937 cells were grown in
RPMI-1640 medium supplemented with 10% fetal bovine serum
and 2 mM L-glutamine. CHO cells were propagated in Ham’s
F12K medium supplemented with 10% FBS. The media also
contained 1% penicillin/streptomycin. The media and its
components were purchased from Mediatech Cellgro (Herdon,
VA) except for serum (Atlanta Biologicals, Norcross, GA).
EP exposure and viability assays for suspension cell lines
Cells were harvested during the logarithmic growth phase,
pelletedbycentrifugation,andresuspendedinfreshgrowthmedium
at either 0.6 or 1.2610
6 cells/ml. The suspension was dispensed
into conventional electroporation cuvettes with 1- or 2-mm gap
between the electrodes (BioSmith Biotech, San Diego, CA). The
cuvettes were exposed to EPs at room temperature (21–23uC), one
cuvette at a time. The exposure protocols were organized so that to
(1) minimize waiting of aliquoted cells for EP exposure to less than
10 min (on a few occasions, up to 20 min), (2) ensure the same
treatment conditions for parallel samples, so that the only variable
would be the EP exposure regimen, and (3) carefully randomize all
EP treatments, including ‘‘sham’’ exposures.
Unipolar EPs of 300-ns, 4.5- or 9.0-ms duration and up to 1-kV
amplitude were generated by an AVTECH AVOZ-D2-B-ODA
pulser (AVTECH Electrosystems, Ottawa, Ontario, Canada). To
produce pulse trains of predetermined duration at selected pulse
repetition rates, this generator was triggered externally from a model
S8800 stimulator (Grass Instruments Co., Quincy, MA). The pulse
amplitude and shape (trapezoidal, with rise and fall times (20%–
80%) of ,100 ns) were monitored using a Tektronix TDS 3052B
oscilloscope. Pulses were delivered to the electroporation cuvette
using a 50- to 10-Ohm transition module (AVOZ-D2-T, AVTECH
Electrosystems) modified into a cuvette holder. The E-field values
were obtained by dividing the mean pulse voltage (as measured by
the oscilloscope) by the width of the gap in the electroporation
cuvette. The absorbed dose was calculated as the energy delivered to
the sample normalized to the mass of the sample [49].
Sample temperature during and after EP exposure was checked
with a fiber optic ReFlex-4 thermometer (Nortech Fibronic,
Quebec City, Quebec, Canada), and never exceeded 30uC.
Cell survival was measured either in 24 hr post exposure using
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) assay, or in 4 hr post exposure by a fluorescent dye
exclusion/quenching method.
For the MTT assay (BioAssay Systems, Hayward, CA), exposed
cells were aseptically aliquoted into a 96-well plate, in triplicates at
50610
3 cells/well, and diluted to 100 ml with fresh growth
medium. The plate was incubated at 37uC, with 5% CO2 in air.
At 20 hr after EP treatment, 10 ml of the MTT reagent were
added to each well, and incubation continued for additional 4 hr.
Formed blue formazan crystals were dissolved by adding the
solubilization buffer (100 ml/well) and placing the plate on an
orbital shaker overnight. Absorbance at 570 nm was read the next
day using Synergy 2 microplate reader (BioTEK, Winooski, VT).
With the MTT assay, cell survival was considered proportional
to the sample absorbance, and was expressed in % to the
absorbance of the sham-exposed parallel control samples. The
results are presented in the graphs and text as mean values +/2s.e.
for a minimum of three independent experiments (usually 5–12
experiments).
For the dye exclusion/quenching method, aliquots of exposed
cells were transferred into microcentrifuge tubes and left in the
incubator until analysis (the tube lid was left open). At 4 hr post
exposure, 20 ml of the cell suspension were mixed with equal
volume of staining solution (100 mg/ml of propidium iodide and
0.5 mg/ml of acridine orange in phosphate-buffered saline). The
dyes and chemicals were purchased from Sigma–Aldrich (St.
Louis, MO). The sample was immediately loaded into a counting
chamber of the automated cell counter Cellometer Vision with
two-channel cell fluorescence detection (Nexcelom Bioscience
LLC, Lawrence, MA).
Both employed dyes markedly increase fluorescence upon
binding to DNA; while acridine orange readily penetrates the
intact cell membrane, propidium does not. Live cells were
distinguished by bright fluorescence of acridine orange (excita-
tion/emission 475/535 nm). In cells with damaged membrane
(presumably dead), this signal was quenched by fluorescence
resonance energy transfer to propidium that entered the cell and
bound to DNA. Combined fluorescence of either acridine orange
or propidium (excitation/emission 525/595 nm) was used to
determine the total (live + dead) cell count.
When using the dye exclusion/quenching assay, cell survival was
expressed as a percentage of live cells to the total number of cells
counted in each slide (usually several hundreds of cells), and two
slides were processed for each datapoint. The survival data were
presented as a mean+/2 s.e for 3–7 independent experiments.
EP exposure of individual cells on a coverslip and
fluorescent microscopy
The procedures were similar to those described recently [11,53].
For the passage immediately preceding experiments, CHO cells
were transferred onto glass cover slips pre-treated with poly-L-
lysine to improve cell adhesion. After several hours, a cover slip
with cells was transferred into a glass-bottomed chamber (Warner
Instruments, Hamden, CT) mounted on an Olympus IX71
inverted microscope equipped with an FV 300 confocal laser
scanning system (Olympus America, Center Valley, PA). The
chamber was filled with a buffer composed of (in mM): 136 NaCl,
5 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, and 10 Glucose (pH 7.4),
with addition of 30 mg/ml of propidium iodide. The buffer
osmolality was at 290–300 mOsm/kg, as measured with a freezing
point microosmometer (Advanced Instruments, Inc., Norwood,
MA). The chemicals were purchased from Sigma–Aldrich.
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with a pair of tungsten rod electrodes (0.08-mm diameter,
0.15 mm gap). With a help of a robotic micromanipulator (MP-
225, Sutter, Novato, CA), these electrodes were positioned
precisely at 50 mm above the coverslip surface so that the selected
cells were in the middle of the gap between their tips. Nearly
rectangular 60-ns pulses were generated in a transmission line-type
circuit, by closing a MOSFET switch upon a timed delivery of a
TTL trigger pulse from pClamp software via a Digidata 1322A
output (MDS, Foster City, CA). The exact PRF, the EP delivery
protocol, and synchronization of EP delivery with image
acquisitions were programmed in pClamp.
The E-field between the electrodes was determined by 3D
simulations with a finite element Maxwell equations solver Amaze
3D (Field Precision, Albuquerque, NM). The exact EP shapes and
amplitudes were captured and measured with a Tektronix TDS
3052 oscilloscope.
Differential-interference contrast and fluorescent images of cells
(excitation: 488 nm; emission 605 nm) were collected every 10 sec
(starting exactly 50 s prior to the first EP) using a 60x, 1.42 NA oil
objective. Photomultiplier tube settings were biased towards high
sensitivity and detection of even minimal propidium uptake,
although massive uptake caused detector saturation. Images were
quantified with MetaMorph v. 7.5 (MDS). All experiments were
performed at a room temperature of 22–24uC.
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